Members of the regulator of complement activation (RCA) protein family perform a vital role in health and disease. In this report we describe our efforts to solve the structures of human membrane cofactor protein (CD46), the vaccinia virus complement control protein, which mimics mammalian RCA proteins, and human complement receptor type 1 (CD35). These examples illustrate that, despite good progress over the last decade, the regulators of complement, as extracellular multiple domain glycoproteins, still pose formidable problems to structural biologists. Many important questions remain unanswered, in particular with regard to the flexibility of these proteins and the extent to which they undergo conformational rearrangements on engaging their binding partners.
In the case of the RCA protein family, progress in structural biology has been hampered by the multiple domain nature of these glycoproteins. For example, the extracellular portion of the most common allotype of complement receptor (CR) type 1 (or CD35) is composed of 30 domains known as complement control protein modules (CCPs), while CR type 2 has 1 5 or 16 CCPs, and other RCA proteins have at least four each. Each CCP consists of about 60 amino acids, has a consensus sequence characterized by four cysteine residues (disulphide-linked 1-11 I and 11-IV) with a tryptophan residue located between Cys 111 and Cys IV, and is connected to its neighbours by just a few residues. CCPs also occur in other complement components including C1 r, Cls, C2, Factor B, C6 and C7; they are additionally found in a further several dozen mammalian proteins.
Multiple domain glycoproteins may be both extended and flexible. They therefore present a challenge to X-ray crystallography, which is better suited to globular proteins. In the first place, such proteins are more difficult to crystallize and, for many years, no crystal structures of RCA proteins were solved. T h e crystal structure of the two N-terminal modules of membrane cofactor protein (i.e. MCP-1 and MCP-2) was the first to be elucidated, in 1999 [2] , and the most recent was the structure of the four CCPs of intact vaccinia virus complement control protein (VCP) [3]. Arguably, the most informative crystal structure so far is that of the two N-terminal CCPs of CR2 in complex with their ligand C3d [4] . T h e crystal structures of MCP and VCP, however, illustrate a second difficulty with the crystallographic approach to multiple domain proteins ; crystal packing forces may stabilize conformers that are not representative of those found amongst dispersed protein molecules at the cell surface or in solution. Moreover, information concerning the flexibility of such proteins, which may be critical to function, might be lost due to crystal contacts. Several further crystal structures of other proteins and protein fragments containing between one and five CCPs have been solved in recent years [5] [6] [7] .
An alternative strategy, pioneered by Ian Campbell at the University of Oxford [8, 9] , is to express individual domains and pairs of domains, and to study their structures using NMR. NMR has the advantage of allowing study in solution, in the absence of crystallographic contacts, and to analyse quantitatively the flexibility of each intermodular junction. A disadvantage is that increasing spectral complexity limits the possibility of extending the NMR approach to longer chains of CCP modules; this would be desirable because it would allow the context-dependency of module structure and dynamics to be examined. Another shortcoming of NMR is its requirement for isotopic labelling. In order to obtain sufficient experimental restraints for a structure determination by NMR, it is normally necessary to replace ''C and 14N with 13C and 15N respectively. This may be achieved cost-effectively in bacteria and yeast that can be raised on minimal media containing '3C-glucose and 15N-ammonium salts. T h e requirement for labelling, however, renders mammalian expression systems, with more complex nutritional requirements, prohibitively expensive, yet mammalian protein expression systems are required for some post-translational modifications such as correct glycosylation.
Thus, whichever approach is taken, there are associated problems that it is desirable to circumvent. In our laboratories we have applied both X-ray crystallography and the 'Campbell strategy', and had variable success in our endeavours to elucidate the structures of several RCA proteins. In this report we briefly outline problems encountered with three of them : MCP, VCP and C R l . Each illustrates a different aspect of the challenge. T h e structural insights afforded and the short-comings of the results obtained are discussed. This report does not deal with structural studies of complexes involving RCA proteins. With the notable exception of CR2-C3dg, these are lacking due to the size and complexity of the chief binding partners, C3b and C4b.
Membrane cofactor protein
MCP inhibits inappropriate activation of the complement system at the host cell surface. This protein has been hijacked by the measles virus, which binds to the two N-terminal CCP modules (i.e. MCP-1 and MCP-2) [lO,ll] . Each of these two CCPs possesses an N-linked glycosylation site. Glycosylation of MCP-2 is required for MCP to act efficiently as a measles virus receptor [12] , although high mannose and complex glycans are both apparently sufficient. This N-linked glycan (along with a further N-glycan on MCP-4) also plays a role in the function of MCP as a complement inhibitor [13] . These findings imply a structural role for the N-glycan attached to MCP-2.
The crystal structure of MCP-1-MCP-2 [2] expressed in Chinese-hamster ovary cells appears to confirm this; it revealed contacts between the N-glycan of module 2 and three different pstrands. The glycan shields hydrophobic sidechains from the solvent. It is therefore possible that the glycan is stabilizing the protein, although this arrangement of the carbohydrate could be due to an artefact of crystallization. The crystal structure of MCP-1-MCP-2 raises questions concerning the intermodular junction [ 141. While intermodular angles do not vary much amongst six crystallographically independent molecules of MCP-1-MCP-2, the intermodular interface buries only a small surface area and the intramolecular contacts involved are significantly less in extent than intermolecular crystal contacts, suggesting the orientations seen in the crystal may be unrepresentative of those in a physiological setting. This is important since the virus appears to contact residues on both modules. T h e determination of a solution structure of MCP-1-MCP-2 derived from NMR data would address these issues and allow insights into its flexibility. From the foregoing discussion, it is clearly preferable to solve the structure of a glycosylated version of MCP-1-MCP-2.
T h e initial problem with a solution (NMR) study of a glycoprotein is the production of the necessary quantities of properly processed and isotopically labelled protein ; a second problem arises due to the difficulty of ensuring the sample is homogeneous. Expression of proteins in the methylotrophic yeast, Pichia pastoris, may solve the first of these problems: its simple media requirements allow isotopic labelling of proteins, which may be expressed at high yield. T h e advantage of yeast over prokaryotic systems is its ability to perform some of the post-translational modifications found in eukaryotic proteins, such as disulphide bond formation and N-glycosylation.
We therefore expressed the two N-terminal CCPs of MCP in P . pastoris as a double module and as two single modules. T h e heteronuclear single-quantum coherence (HSQC) spectrum of "N-labelled MCP-1-MCP-2 before (data not 
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shown) or after ( Figure 1A ) glycosidase treatment (leaving an N-acetylglucosamine unit attached to the protein) was unpromising because the expected number of resolved cross-peaks (there should be one for each amide (NH) moiety in the protein)
could not be observed, while a clump of crosspeaks in the 'random-coil' region (towards the centre) of the spectrum is consistent with the presence of a significant proportion of poorly ordered protein structure. MCP-1 ; I " " " " " " " " " ' ; " " h 10
It was therefore inferred that the problems with MCP-I-MCP-2 resided in MCP-2. T o investigate further, MCP-2 was expressed alone in P. pastoris. Although expression levels were sufficient for biophysical studies, this recombinant glycoprotein illustrated a major drawback of expression in P. pastoris : that of hyperglycosylation. P. pastoris typically adds 2-3 kDa of sugar per N-glycosylation site but Figure 1(C) shows the level of hyperglycosylation (1 8-3 5 kDa of sugar) when MCP-2 is expressed in P. pastoris, and the outcome of enzymically removing these sugars. Figure 1(D) illustrates the quality of the 15N,lH HSQC spectrum obtained for the glycosylated sample ; the dispersion of cross-peaks is consistent with predominantly folded protein and their linewidths are as expected for the larger molecular mass. Such a sample is unsuitable for structure determination due to the spectral complexity contributed by the glycans and its chemical heterogeneity. After deglycosylation (Figure 1 E) , there is a larger quantity of overlap in the centre of the spectrum than one would expect for a protein of its size; furthermore, there is an insufficiency of cross-peaks. The module has not folded properly and the most likely reason is that its N-glycan is a structural requirement.
In summary, while the X-ray crystal structure of MCP-1-MCP-2 yielded important insights, it did not address definitively the key question of intermodular angles between CCPs 1 and 2. On the other hand, NMR has so far failed to deliver satisfactory results due to the difficulty of preparing a glycoprotein with a structurally critical N-glycan from a non-mammalian expression system suitable for isotopic labelling.
Vaccinia virus complement control protein
VCP is a complement inhibitor expressed by cells infected with the vaccinia virus (homologues are expressed by other pox viridae). It assists the virus to avoid complement-mediated elimination [ 151.
Expression in P. pastoris of VCP, which is comprised wholly of four CCPs and is unique amongst this family in having no N-glycosylation sites, was straightforward and resulted in crystal structures of the intact protein [3], and NMR-derived structures of fragments [16, 17] , but neither approach tells the whole story, illustrating another difficulty with the structural biology of multiple-domain proteins.
T h e crystal structure of intact VCP (crystallized at 18 "C) indicates a rod-like structure with modules arranged end-to-end. Essentially, the same arrangement of the four CCPs was observed in five crystallographically independent VCP molecules in two crystal forms, in spite of the limited buried surface area between modules ; the interface between the central modules, 2 and 3, is the smallest (approx. 250 A*). As with MCP, crystal packing would constrain intermodular motion and therefore the following questions again arise. Is the conformation in the crystals representative of the most populated conformers in solution ? How flexible are the junctions and therefore is the protein likely to undergo a conformational rearrangement of modules when it binds to its targets (it has been reported that all four CCPs are required for full biological function [15] )? NMR and other biophysical studies on double-module fragments (VCP-2-VCP-3 and VCP-3-VCP-4) [ 181 show flexibility between modules 2 and 3 (at 37 "C) in solution, in contrast to a more rigid 3-4 interface that closely resembles in the NMR structure its crystallized equivalent. It remains unclear if the flexibility in the solution studies is an artefact arising from the truncated nature of the VCP fragments. This is possible given the differences observed between structures of VCP-2, depending upon its context. Although the major difference between VCP-2 in the context of VCP-2-VCP-3, and in the context of intact VCP, resides in the loops of VCP-2 that lie close (in intact VCP) to VCP-I, there are further significant structural differences propagated throughout the module that may in turn influence the VCP-2-VCP-3 junction. It is hoped that ongoing studies using X-ray scattering will help to resolve whether or not intact VCP is flexible in solution.
In summary, while the crystal structure leaves questions unanswered regarding the flexibility of VCP, the comparison of NMR and X-ray structures illustrates that this protein appears to lack true modularity in that the component modules are not structurally independent of their neighbours. This exemplifies a difficulty for the 'dissect and rebuild' approach. Moreover, it is worth remarking that most experiments to identify which CCPs in a particular protein are responsible for function depend upon module deletion and substitution, and make the assumption of ideal modularity.
Complement receptor type I
T h e 30 CCPs of CR1 fall into four long homologous repeats (LHRs) of seven modules (plus CRI-8-CR1-10 and CRl-15-CR1-17 are 99*, identical and are considered to be two copies of 'site 2'. Site 2 is the principal binding site for C3b and is therefore key to the role of C R l as the immune adherence receptor : the erythrocyteborne receptor for C3b-coated particles that ensures clearance of immune complexes, and the receptor on follicular dendritic cells and most phagocytic cells for C3b-coated ligands.
Our goal was to solve the structure of site 2 and thereby reveal the basis of immune adherence.
In this case the presence of glycans is unnecessary for function and the glycosylation sites were mutated out prior to P. pastoris expression of isotopically labelled CRI-15-CR1-17. Once again, N M R experiments proved to be problematic. In this case, although spectra were consistent with folded proteins, cross-peaks were broad and extensively overlapped. Broad N M R peaks are normally symptomatic of protein aggregation or another phenomenon leading to slow tumbling (rapid relaxation of the N M R signal) in solution.
Although there was no evidence of multimerization according to ultracentrifugation studies, diluting the NMR sample induced a sharpening of peaks in the spectra; but such samples were too 
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weak for structure determination. In effect the protein, although quite small (22 kDa) by NMR standards, was behaving like a larger one, perhaps due to self-association, or possibly due to anisotropy of rotational diffusion. This was circumvented by provision of an 80% deuterated (zH,'3C,15N) sample and application of the TROSY (transverse-relaxation optimized spectroscopy) NMR [20] technique that is designed to overcome problems of rapid relaxation (slow tumbling). It was thus possible to assign most 'H, 13C and 15N nuclei in the protein to specific NMR frequencies, but the sample was unsuitable for the nuclear Overhauser effect (N0E)-type experiments required to provide the distance restraints that are used in three-dimensional structure calculation. T o progress further it was necessary to express overlapping pairs of CCPs (CR1-1 5-CR1-16 and CR1-16-CR1-17) which proved amenable to standard NMR techniques [21] . T h e structure of CCP-16 was similar in both contexts (with the exception of loops near the interface with neighbouring modules) and it was possible to re-build the structure of CRl-15-CR1-17 by overlaying the common structure of module 16. Thus, in this case the protein did behave in a truly modular fashion. The modules are arranged end-to-end ( Figure 2 ) producing an elongated structure that could explain the anisotropy of rotational diffusion and the consequently broad NMR cross-peaks.
T h e orientation of modules 15 and 17 with respect to 16 was not fully defined by the data. While a network of distance restraints (i.e. NOEs) constrained the 15-16 junction in the structure calculation, only a small number of NOEs could be found between modules 16 and 17. This coincided with a range of biophysical studies that had suggested the 15-16 junction of CRl was more defined than the 16-17 junction. An additional structural restraint was provided by residual dipolar couplings (RDCs). These become measurable when the sample is partially aligned within the NMR tube using liquid crystal-like media, providing long-range structural information since they relate N H bond vectors to a common axis. T h e RDCs confirmed the arrangement of modules 15 and 16 that was inferred from NOEs. It has not proved possible so far, however, to quantitate intermodular flexibility, partly because it is difficult to deconvolute intermodular motion from motion of the entire protein. Another complication is that although CR1-16 appears to be structurally independent of context, its dynamics are not. Therefore the extent of inter-995 modular flexibility observed in double-module fragments might be different when the modules are in the intact protein.
In summary, the solution structure determination of site 2 of CR1 was successful thanks to the production of many isotopically labelled samples. It subsequently proved possible to rationalize existing mutagenesis and design new mutants; taken together these defined a C3b- 
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T h e short consensus/complement repeat (SCR) domain (also known as the complement control protein domain) is the most abundant domain type in the complement system. Crystal and N M R structures for proteins that contain single and multiple SCR domains have now been published. These contain inter-SCR linkers of between three and eight residues, and the structures show much variability in inter-SCR orientations. X-ray and neutron scattering, combined with analytical ultracentrifugation and constrained modelling based on known subunit structures will yield a medium-resolution structure for the protein of interest. T h e fewer parameters that are associated with the structure of interest, the more defined the structure of interest becomes. These solution studies have been applied to several SCRcontaining proteins in the complement system, most notably Factor H with 20 SCR domains, a complement receptor type 2 fragment with two SCR domains, and rat complement receptorrelated protein (Crry) which contains five SCR domains. T h e results show great conformational variability in the inter-SCR orientation, and these will be reviewed. Even though the rotational orientation cannot be modelled, it is nonetheless possible to measure the degree of extension of the multi-SCR proteins and, from this, to obtain functionally useful results.
The complement system
T h e components of the complement system provide a major non-adaptive immune defence mechanism for the host [l] . These are activated in response to the challenge of foreign material in plasma, with C3 being the central complement protein.
Complement activation proceeds through a series of limited proteolytic steps in one of three pathways : the alternative, the classical and the lectin pathway. In the alternative pathway, the deposition of C3b on foreign surfaces is amplified by interactions with the Bb fragment which is formed b y the action of the serine proteases Factor B and Factor D , and controlled by the cofactor Factor H (FH) and the serine protease Factor I .
T h e C3b-Bb complex converts C3 into C3b; C3b is an essential component of C5-cleaving enzymes. One of the breakdown products of C3b is C3d, which remains attached to the foreign antigen, and this is bound by complement receptor type 2 (CR2, CD21). T h e cross-linking of CR2 to the B-cell receptor through a C3d-antigen complex amplifies a signal transduction cascade through a co-activation complex with CD19 and CD81 [2].
In addition, CR2 is the receptor for CD23 and the Epstein-Barr virus. Proteins such as F H are central to the activation of the complement pathways, while complement receptors such as CR2 provide a key interface between the innate and adaptive immune systems.
